Upgrade to SI Premium - Free Trial

Abbvie (ABBV) PT Raised to $300 at Wells Fargo

August 17, 2026 6:26 AM
Wells Fargo analyst Mohit Bansal raised the price target on Abbvie (NYSE: ABBV) to $300.00 (from $295.00) while maintaining a ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change